Skip to content

PLUSPROPHARMA

Active
Private limited companyfounded 2012active for 14 yearsNijverheidslaan 1587, 3660 Oudsbergen, BelgiumKBO/BCE: BE 0844.371.241
Summary

PLUSPROPHARMA has been active since 2012 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €121,956 and a net result of -€8,374. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 56% of 13,595 sector peers (NACE 46, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Overview

Activity
Agents in the wholesale of food, beverages and tobacco
NACE 46170
1 site
Size
€251,963total assets 2025
Equity
€121,956
Loss
-€8,374
Turnover not published (micro format)
Financial health
87 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.2%
Structure
Accounts 28 days early1 of 4 deeds read
Why 87raises riskLoss of €8,374, the second in a row (financial year 2025)lowers riskFounded in 2012Liquidity: current ratio 2.54, cash €28,751Equity €121,956 (48.4% of total assets)Show the evidence

Checked score

Score 2025
87 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 38% of its sector peers (NACE 46, micro)
Financial strength · tick = 2024
Average
Solvency 73-1
equity 48.4% of total assets
Liquidity 47+4
short-term debt 37.9% · cash 11.4%
Profitability 15+13
return on assets -3.3%
Bankruptcy probability, 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%

About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.4% (26,862 companies, NACE 46, micro)
Last 24 months 11-2024: 0.4% 12-2024: 0.4%● unchanged vs 11-2024 01-2025: 0.4%● unchanged vs 12-2024 02-2025: 0.4%● unchanged vs 01-2025 03-2025: 0.4%● unchanged vs 02-2025 04-2025: 0.4%● unchanged vs 03-2025 05-2025: 0.4%● unchanged vs 04-2025 06-2025: 0.4%● unchanged vs 05-2025 07-2025: 0.5%▲ +0.1 percentage points vs 06-2025 08-2025: 0.5%● unchanged vs 07-2025 09-2025: 0.5%● unchanged vs 08-2025 10-2025: 0.5%● unchanged vs 09-2025 11-2025: 0.5%● unchanged vs 10-2025 12-2025: 0.5%● unchanged vs 11-2025 01-2026: 0.5%● unchanged vs 12-2025 02-2026: 0.5%● unchanged vs 01-2026 03-2026: 0.5%● unchanged vs 02-2026 04-2026: 0.5%● unchanged vs 03-2026 05-2026: 0.5%● unchanged vs 04-2026 06-2026: 0.5%● unchanged vs 05-2026 07-2026: 0.5%● unchanged vs 06-2026highest value 08-2026: 0.2%▼ -0.3 percentage points vs 07-2026lowest value 09-2026: 0.2%● unchanged vs 08-2026lowest value 10-2026: 0.2%● unchanged vs 09-2026lowest value
Credit of up to €10,000 on 30-day terms is acceptable
Liquidity ample (current ratio 2.54, compared with 2.57 in 2024, above the usual 1.5; short-term debt: 37.9% and cash: 11.4% of total assets), but 51.6% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 46, micro): better than 56% on solvency, 46% on liquidity, 19% on profitability and 29% on growth.

The bankruptcy probability was computed on 21-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Founded in 2012
Companies that have existed this long fail less often; how much that weighs depends on the rest of its profile.
KBO
raises risk · Loss of €8,374, the second in a row (financial year 2025)
NBB · annual accounts
lowers risk · Liquidity: current ratio 2.54, cash €28,751
NBB · annual accounts
lowers risk · Equity €121,956 (48.4% of total assets)
NBB · annual accounts
raises risk · Persistent losses
Two consecutive loss-making years (2024 and 2025); equity is also lower. May indicate structural pressure on profitability.
NBB · annual accounts 2025
Net result per financial year
1819202122232425
2018 to 2025 · latest year -€8,374
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 03-07-2026, 28 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
28 days early
2024
24 days early
2023
30 days early
2022
19 days early
2021
13 days early
2020
25 days early
2019
23 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 23 days before the deadline; the sector median (NACE 46) for financial year 2024 is 3 days before the deadline, and 39% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 7 July (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
22-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. Annual accounts filedfinancial year 2024 · micro…
  3. Annual accounts filedfinancial year 2023 · micro…

Financials · financial year 2025, micro format

Equity
€121,956▼ 6.4%
2024 · €130,329
Total assets
€251,963▼ 5.2%
2024 · €265,854
Net result
-€8,374▲ 76.3%
2024 · -€35,404
Working capital
€147,309▼ 3.1%
2024 · €152,075
Trend over the years

2021 to 2025, 5 financial years 2018 to 2025, 8 financial years

The operating result stays negative: a loss of €8,099 in 2025 against €30,381 in 2024; the loss shrinks.

What the company sold each financial year and what was left of it. A loss stands below the zero line.

Operating result-€8,099 2025 Net result-€8,374 2025

Use the arrow keys on the chart for the figures per year.

Sector: the middle half of NACE 46, Wholesale trade: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA), Staff (FTE).

Every figure with its change against the financial year before
favourable unfavourable
Line20182019202020212022202320242025
Operating result€5,028-€16,237▲ 223%€137,527▲ 747%€164,160▲ 19.4%€102,168▼ 37.8%-€68,790-€30,381▲ 55.8%-€8,099▲ 73.3%
Net result€1,231-€12,124▲ 885%€115,330above the sector's middle half▲ 851%€116,401above the sector's middle half▲ 0.9%€73,539above the sector's middle half▼ 36.8%-€73,695below the sector's middle half-€35,404below the sector's middle half▲ 52.0%-€8,374below the sector's middle half▲ 76.3%
Equity-€77,965--€65,841▲ 15.6%€49,489within the sector's middle half€165,890above the sector's middle half▲ 235%€239,428above the sector's middle half▲ 44.3%€165,734above the sector's middle half▼ 30.8%€130,329within the sector's middle half▼ 21.4%€121,956within the sector's middle half▼ 6.4%
Total assets€69,190-€104,239▲ 50.7%€229,259within the sector's middle half▲ 120%€574,387above the sector's middle half▲ 151%€407,566above the sector's middle half▼ 29.0%€377,957within the sector's middle half▼ 7.3%€265,854within the sector's middle half▼ 29.7%€251,963within the sector's middle half▼ 5.2%
Debt€147,155-€170,080▲ 15.6%€179,770▲ 5.7%€408,497▲ 127%€168,137▼ 58.8%€212,224▲ 26.2%€135,525▼ 36.1%€130,008▼ 4.1%
Working capital-€79,165--€66,441▲ 16.1%€53,380within the sector's middle half€161,137above the sector's middle half▲ 202%€213,297above the sector's middle half▲ 32.4%€171,622above the sector's middle half▼ 19.5%€152,075above the sector's middle half▼ 11.4%€147,309above the sector's middle half▼ 3.1%
Solvency-112.7%--63.2%▲ 49.5pp21.6%within the sector's middle half▲ 84.7pp28.9%within the sector's middle half▲ 7.3pp58.7%within the sector's middle half▲ 29.9pp43.8%within the sector's middle half▼ 14.9pp49.0%within the sector's middle half▲ 5.2pp48.4%within the sector's middle half▼ 0.6pp
Current ratio0.46-0.61▲ 0.151.31within the sector's middle half▲ 0.701.41within the sector's middle half▲ 0.112.32within the sector's middle half▲ 0.901.94within the sector's middle half▼ 0.372.57within the sector's middle half▲ 0.622.54within the sector's middle half▼ 0.03
Return on assets (ROA)1.8%-11.6%▲ 9.9pp50.3%above the sector's middle half▲ 38.7pp20.3%above the sector's middle half▼ 30.0pp18.0%above the sector's middle half▼ 2.2pp-19.5%below the sector's middle half▼ 37.5pp-13.3%below the sector's middle half▲ 6.2pp-3.3%within the sector's middle half▲ 10.0pp
Staff (FTE)1-1=1within the sector's middle half=0.1▼ 90.0%0.3▲ 200%1▲ 233%0.2▼ 80.0%
above within below the middle half of NACE 46, Wholesale trade: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30.
Turnover and EBIT margin not published: the micro format does not require them.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €251,963
Fixed assets €9,163 ▼ 45.5%
Current assets €242,800 ▼ 2.5%
Equity and liabilities €251,963
Equity €121,956 ▼ 6.4%
Debt €130,008 ▼ 4.1%
Debt's share of the balance-sheet total rises from 51.0% to 51.6%. Equity and debt are lower.
Key figures and ratios
2025 value · change against 2024
EBITDA
-€450▲
2024 · -€22,722
Cash flow
-€724▲
2024 · -€27,745
Quick ratio
1.12▼
2024 · 1.18
Debt to equity
1.07▲
2024 · 1.04
ROE
-6.9%▲
2024 · -27.2%
Interest coverage
-0.42▲
2024 · -4.40
Debt ≤ 1 year
€95,491▼
2024 · €96,966
Debt > 1 year
€4,516▼
2024 · €8,516
Staff costs
-€357▼
2024 · €7,019
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 6,910 companies that looked in July 2024 the way this one looks now, 1.1% went bankrupt within 24 months and 90.9% are still going.

  • Micro
  • 10 to 20 years old
  • solvency 30% or more
  • a small loss
1.1% went bankrupt
7.8% stopped otherwise
90.9% still going

A further 0.2% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a bankruptcy probability of 0.2% over twelve months; the group does not contradict it.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,473 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 6,910 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 46 lines
Balance sheet Code20242025
Assets
Total assets20/58€265,854€251,963▼
Fixed assets21/28€16,813€9,163▼
Tangible fixed assets22/27€16,813€9,163▼
Furniture and vehicles24€16,813€9,163▼
Current assets29/58€249,041€242,800▼
Stocks and contracts in progress3€135,032€136,249▲
Stocks30/36€135,032€136,249▲
Amounts receivable within one year40/41€91,509€75,929▼
Trade receivables40€63,423€46,927▼
Other amounts receivable41€28,087€29,002▲
Cash at bank and in hand54/58€20,577€28,751▲
Deferred charges and accrued income490/1€1,923€1,871▼
Equity and liabilities
Total equity and liabilities10/49€265,854€251,963▼
Equity10/15€130,329€121,956▼
Contributions10/11€18,550€18,550=
Reserves13€220,878€220,878=
Distributable reserves133€220,878€220,878=
Profit (loss) carried forward14-€109,099-€117,473▼
Amounts payable17/49€135,525€130,008▼
Amounts payable after more than one year17€8,516€4,516▼
Financial debts170/4€8,516€4,516▼
Amounts payable within one year42/48€96,966€95,491▼
Current portion of amounts payable after more than one year42€4,157€4,000▼
Financial debts43€8,486€8,430▼
Credit institutions430/8€8,486€8,430▼
Trade debts44€6,565€5,957▼
Suppliers440/4€6,565€5,957▼
Taxes, remuneration and social security45€6,519€5,779▼
Taxes450/3€3,669€2,909▼
Remuneration and social security454/9€2,850€2,870▲
Other amounts payable47/48€71,239€71,326▲
Accrued charges and deferred income492/3€30,042€30,000▼
Income statement Code20242025
Remuneration, social security and pensions62€7,019-€357▼
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€7,659€7,650▼
Other operating charges640/8€906€1,031▲
Gross operating margin9900-€14,798€224▲
Operating profit (loss)9901-€30,381-€8,099▲
Financial income75/76B€140€791▲
Recurring financial income75€140€791▲
Financial charges65/66B€5,163€1,066▼
Recurring financial charges65€5,163€1,066▼
Profit (loss) for the period before taxes9903-€35,404-€8,374▲
Profit (loss) for the period9904-€35,404-€8,374▲
Profit (loss) for the period to be appropriated9905-€35,404-€8,374▲
Appropriation of the result
Profit (loss) to be appropriated9906-€109,099-€117,473▼
Profit (loss) brought forward from the previous period14P-€73,695-€109,099▼

The notes to these accounts (6 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20182019202020212022202320242025Change
Remuneration, social security and pensions62---€3,702€13,737€44,552€7,019-€357-
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€600€600€609€527€5,628€7,659€7,659€7,650▼ 0.1%
Other operating charges640/8---€410€596€847€906€1,031▲ 13.8%
Gross operating margin9900€39,427€49,299€171,766€168,798€122,128-€15,732-€14,798€224-
Operating profit (loss)9901€5,028€16,237€137,527€164,160€102,168-€68,790-€30,381-€8,099▲ 73.3%
Financial income75/76B---€1,945€1,449€174€140€791▲ 467%
Recurring financial income75€109€111€522€1,945€1,449€174€140€791▲ 467%
Financial charges65/66B---€2,740€2,694€5,078€5,163€1,066▼ 79.4%
Recurring financial charges65€3,906€4,224€4,257€2,740€2,694€5,078€5,163€1,066▼ 79.4%
Profit (loss) for the period before taxes9903€1,231€12,124€133,792€163,365€100,922-€73,695-€35,404-€8,374▲ 76.3%
Income taxes67/77--€18,462€46,964€27,383----
Profit (loss) for the period9904€1,231€12,124€115,330€116,401€73,539-€73,695-€35,404-€8,374▲ 76.3%
Profit (loss) for the period to be appropriated9905€1,231€12,124€115,330€116,401€73,539-€73,695-€35,404-€8,374▲ 76.3%
Line20182019202020212022202320242025Change
Assets
Total assets20/58€69,190€104,239€229,259€574,387€407,566€377,957€265,854€251,963▼ 5.2%
Fixed assets21/28€1,200€600€2,109€22,752€32,131€24,472€16,813€9,163▼ 45.5%
Tangible fixed assets22/27€1,200€600€2,109€22,752€32,131€24,472€16,813€9,163▼ 45.5%
Furniture and vehicles24---€22,752€32,131€24,472€16,813€9,163▼ 45.5%
Current assets29/58€67,990€103,639€227,151€551,635€375,435€353,486€249,041€242,800▼ 2.5%
Stocks and contracts in progress3€48,314€65,064€92,983€210,685€173,341€209,991€135,032€136,249▲ 0.9%
Stocks30/36---€210,685€173,341€209,991€135,032€136,249▲ 0.9%
Amounts receivable within one year40/41€19,448€38,089€95,790€323,620€196,714€82,262€91,509€75,929▼ 17.0%
Trade receivables40---€239,065€161,179€51,762€63,423€46,927▼ 26.0%
Other amounts receivable41---€84,554€35,535€30,500€28,087€29,002▲ 3.3%
Cash at bank and in hand54/58--€37,881€17,055€4,342€59,203€20,577€28,751▲ 39.7%
Deferred charges and accrued income490/1---€276€1,038€2,029€1,923€1,871▼ 2.7%
Equity and liabilities
Total equity and liabilities10/49€69,190€104,239€229,259€574,387€407,566€377,957€265,854€251,963▼ 5.2%
Equity10/15-€77,965-€65,841€49,489€165,890€239,428€165,734€130,329€121,956▼ 6.4%
Contributions10/11€18,550€18,550-€18,550€18,550€18,550€18,550€18,550=
Reserves13--€30,939€147,340€220,878€220,878€220,878€220,878=
Distributable reserves133---€147,340€220,878€220,878€220,878€220,878=
Profit (loss) carried forward14-€96,515-€84,391-€96,515---€73,695-€109,099-€117,473▼ 7.7%
Amounts payable17/49€147,155€170,080€179,770€408,497€168,137€212,224€135,525€130,008▼ 4.1%
Amounts payable after more than one year17-----€12,360€8,516€4,516▼ 47.0%
Financial debts170/4-----€12,360€8,516€4,516▼ 47.0%
Amounts payable within one year42/48€147,155€170,080€173,770€390,497€162,137€181,864€96,966€95,491▼ 1.5%
Current portion of amounts payable after more than one year42-----€3,694€4,157€4,000▼ 3.8%
Financial debts43---€8,395€8,333€8,478€8,486€8,430▼ 0.7%
Credit institutions430/8---€8,395€8,333€8,478€8,486€8,430▼ 0.7%
Trade debts44€35,760€31,354€41,874€257,852€73,236€34,320€6,565€5,957▼ 9.3%
Suppliers440/4---€257,852€73,236€34,320€6,565€5,957▼ 9.3%
Taxes, remuneration and social security45---€32,429€10,670€14,470€6,519€5,779▼ 11.4%
Taxes450/3---€27,070€3,849€3,790€3,669€2,909▼ 20.7%
Remuneration and social security454/9---€5,359€6,820€10,680€2,850€2,870▲ 0.7%
Other amounts payable47/48---€91,822€69,899€120,903€71,239€71,326▲ 0.1%
Accrued charges and deferred income492/3---€18,000€6,000€18,000€30,042€30,000▼ 0.1%
Line20182019202020212022202320242025Change
Profit (loss) for the period9904€1,231€12,124€115,330€116,401€73,539-€73,695-€35,404-€8,374▲ 76.3%
+ Depreciation and write-downs630€600€600€609€527€5,628€7,659€7,659€7,650▼ 0.1%
Operating cash flow (approximation)€1,831€12,724€115,939€116,928€79,167-€66,036-€27,745-€724▲ 97.4%
Investment in fixed assets (approximation)-€0-€2,118-€21,170-€15,007€0€0€0-
Change in cash----€20,826-€12,713€54,861-€38,626€8,174-

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Latest 10 of 13 filings with the National Bank
Financial year Type Filed Reference
31-12-2025 micro format 03-07-2026 2026-00246522
31-12-2024 micro format 07-07-2025 2025-00234975
31-12-2023 micro format 01-07-2024 2024-00190709
31-12-2022 micro format 12-07-2023 2023-00226924
31-12-2021 micro format 18-07-2022 2022-20193510
31-12-2020 micro format 06-07-2021 2021-31300310
31-12-2019 micro format 08-07-2020 2020-27500405
31-12-2018 micro format 02-07-2019 2019-26900421
31-12-2017 micro format 27-06-2018 2018-24300003
31-12-2016 micro format 19-07-2017 2017-33400354

Show all 13 filings

Similar companies · same sector, comparable size

Of the 1,603 active companies whose main activity is agents in the wholesale of food, beverages and tobacco (NACE 46170), figures are known for 665. 463 are within a factor 10 of this equity. These 5 are the closest to it. See the whole sector

Subsidies and aid

Flemish government

2022 · 1 entry · €1,785 awarded · €1,785 paid
Schemes
1 entry · €1,785 · €1,785 paid · Fonds voor Innoveren en Ondernemen

Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.

Directors

Directors
1 director, last change in 2024
BERGHS Alexander
Director (not named in the articles) · since 01-02-2024
Current
Derived from published Gazette deeds. The KBO keeps the official list of office holders; we do not read it, so the two can differ. See the directors and other office holders in the KBO →
Not every act has been read: a resignation may still be missing
3 of this company's 4 Belgian Official Gazette deeds have not been read yet. Appointments and resignations recorded in them are not yet in the list of directors: someone who resigned there may still be listed as sitting. The acts are in the Timeline.

Mandate history

1 person since 2024, 1 in office
Show
  • Board
  • began earlier
Mandates per person, with start and end dates
Name Functions and periods
BERGHS Alexander
  • Statutory manager, until 01-02-2024
  • Director (not named in the articles), from 01-02-2024 to date
See the board, name and registered office on a given date →

Owners and capital

Owners

No owners or capital events in the accounts and acts we read.

Group and network

Connections & network

1 current director
Depth

The network starts from this company’s directors. Other companies they run appear here as nodes.

This company Company Director Shareholding +N: links not shown yet Click a node to look further, drag to arrange, zoom with the mouse wheel.

History

On 10 March 2012, PLUSPROPHARMA was incorporated.1 Total assets went from €69,190 in 2018 to €251,963 in 2025 and headcount from 1 full-time equivalents in 2018 to 0.2 in 2024.2

  1. 1KBO register
  2. 2National Bank, annual accounts 2018, 2024 and 2025

Acts, filings and financial milestones

Next filing, financial year 2026, expected by 31-07-2027
2026
03-07
NBB filing Annual accounts filed
financial year 2025 · micro format
2025
07-07
NBB filing Annual accounts filed
financial year 2024 · micro format
2024
01-07
NBB filing Annual accounts filed
financial year 2023 · micro format
01-02
Gazette deed Resignation: BERGHS Alexander (statutory manager)
Appointment: BERGHS Alexander (director) · Capital conversion · Reserve release14 facts ▸
  • General meeting, 08-01-2024
  • Other provision, “aanpassing statuten aan Wetboek van vennootschappen en verenigingen en behoud rechtsvorm, aanpassen en behouden” (deed in Dutch)
  • Capital conversion, “statutair onbeschikbare eigen vermogensrekening” (deed in Dutch)
  • Reserve release, “vormen en meerderheden van statutenwijziging, statutair onbeschikbare eigen vermogensrekening aangelegd bij toepassing artikel 39,§2,derde lid wet van 2019-03-2…” (deed in Dutch)
  • Amendment of the articles
  • Other provision, “mogelijkheid tot uitkeren van interimdividenden voorzien, voorzien” (deed in Dutch)
  • Other provision, “voorwerp niet gewijzigd” (deed in Dutch)
  • Capital
  • Director resignation, BERGHS Alexander (statutory manager)
  • Director appointment, BERGHS Alexander (director (not named in the articles))
  • Other provision, “beroepsverbod, geen beroepsverbod uitgesproken” (deed in Dutch)
  • Power of attorney
  • +2 further facts in this act
2023
31-12
Financial Weakest financial yearnet -€73,695
Net result drops to -€73,695, the lowest in the series; recovery starts the following year.
12-07
NBB filing Annual accounts filed
financial year 2022 · micro format
2022
31-12
Financial Equity above €200,000equity €239,428 ▲44.3%
A profit in every financial year since 2018 builds equity to €239,428.
18-07
NBB filing Annual accounts filed
financial year 2021 · micro format
2021
31-12
Financial Highest result from 2018 to 2025net €116,401 ▲0.9%
Operating result €164,160, net result €116,401, both a record.
31-12
Financial Equity above €150,000equity €165,890 ▲235%
A profit in every financial year since 2018 builds equity to €165,890.
06-07
NBB filing Annual accounts filed
financial year 2020 · micro format
2020
31-12
Financial Liquidity more than doubledcurrent ratio 1.31
Current ratio from 0.61 to 1.31.
Show earlier events
08-07
NBB filing Annual accounts filed
financial year 2019 · micro format
2019
02-07
NBB filing Annual accounts filed
financial year 2018 · micro format
2018
27-06
NBB filing Annual accounts filed
financial year 2017 · micro format
2017
19-07
NBB filing Annual accounts filed
financial year 2016 · micro format
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 13 annual accounts filed, the latest 10 are here; all 13 are under Financials.
1 of 4 deeds read
About the unread acts

Of the 4 Belgian Official Gazette deeds we know for this company, 1 has been read. The other 3 have not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Register details

Identification
Legal formPrivate limited company
Founded10-03-2012
Financial year end31-12
Activities, NACEBEL 2025
46170Agents in the wholesale of food, beverages and tobacco
73120Media representation
Contact
E-mail info@medista.beOudsbergen
E-invoicing
Reachable via Peppol
Peppol ID 0208:0844371241
Registered 15-04-2025

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 22 October 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.

Recognitions · licences · registrations

Food safety, FASFC

1 site
Oudsbergenunit no. 2.210.102.339
1 permission
Groothandelaar LM>3 maand · since 01-01-2015

Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.

Sites & property

Location & real-estate footprint
Registered office, Oudsbergen · 1 establishment unit since 2012
registered office establishment The establishment unit on the map
Ground area
2,377 m²
Building footprint
1,419 m²
Building volume
8,730 m³
Parcel 71562B0908/00N008, Flanders · tallest building 8.1 m. Linked by address, not a title deed.
5 companies at this address See who is registered here
1 establishment unit
PlusProPharma
Nijverheidslaan 1587, 3660 OudsbergenWholesale of other food products
since 2012unit no. 2.210.102.339
1 parcel
Flanders 1 (100%)
Cadastral parcel Region Area Buildings Height / floors
71562B0908/00N008 Flanders 2,377 m² 1 · 1,419 m² 8.1 m · 2
How the parcels are linked
Good to know
The parcel matches the address exactly.

Articles of association

What the company does

PurposeThe activities the company may carry out under its articles.
“Het verkopen van voedingssupplementen, cosmetica en geneesmiddelen; Alle verhandelingen van industriële, commerciële, roerende als…” (deed in Dutch)
8 activities (deed in Dutch)
  1. Het verkopen van voedingssupplementen, cosmetica en geneesmiddelen
  2. Alle verhandelingen van industriële, commerciële, roerende als onroerende aard die zich rechtstreeks hierbij aansluiten of in uitbreiding hiervan zijn bedoeld, zoals:
  3. Aan- en verkoop van goederen voor publiciteits-, reclame- en servicedoeleinden
  4. Transporteren, stockeren en afleveren van stalen zonder waarde, die in opdracht van de registratiehouder bezorgd worden aan diverse artsen
  5. Reclame en publiciteitscampagnes voeren
  6. Informatieve prospecties en informatiecampagnes voeren
  7. Opleidingen en opvolging geven van verkoop, van commerciële evenals marketingtechnische aard
  8. Ontwerpen en produceren van eigen producten

The full purpose is in the deed

DurationHow long the company exists; usually unlimited, so until it is dissolved.
Unlimited
Name clauseThe name the company operates under according to its articles.
PlusProPharma
Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
“Administratieve zetels,agentschappen,werkhuizen,stapelplaatsen en bijkantoren in België of buitenland bij enkel besluit bestuursorgaan…” (deed in Dutch)

deed of 01-02-2024

Who represents it, and how

Who signsWho may bind the company towards others, for example by signing a contract.
Each director alone
Board ruleHow the board is made up, meets and takes decisions.
“Bestuursorgaan, 1” (deed in Dutch)

deed of 01-02-2024

Capital, shares and profit

Kind of sharesWhich classes of shares exist and what rights each class carries.
“Alle aandelen op naam, register van aandelen op naam met vermeldingen voorgeschreven door Wetboek van vennootschappen en verenigingen” (deed in Dutch)
Transfer restrictionWhether shareholders may sell their shares freely or need approval first.
One provision in the deed

deed of 01-02-2024

Meetings and financial year

Annual meetingWhen the shareholders meet each year, among other things to approve the annual accounts.
Second Thursday of June at 18:00

deed of 01-02-2024

Oversight and winding up

Dissolution ruleWhen and by whom the company can be dissolved.
“Beslissing algemene vergadering in vormen statutenwijziging, op elk moment” (deed in Dutch)
Liquidation ruleHow assets are shared after dissolution: creditors first, then shareholders.
“Ontbinding en sluiting vereffening in één akte mogelijk mits naleving voorwaarden WVV, bestuurder(s) in functie als vereffenaar(s) krachtens…” (deed in Dutch)

deed of 01-02-2024

Other provisionsOther rules from the articles that fall under none of the themes above.

Other provision: “Stortingsplicht, bestuursorgaan zelfstandig” (deed in Dutch)
Other provision: “Ten minste vijftien dagen te rekenen van dag openstelling intekening, inbreng in geld met uitgifte nieuwe aandelen - recht van voorkeur” (deed in Dutch)
Other provision: “Recht van voorkeur bij vruchtgebruik op aandelen, vruchtgebruiker,tenzij anders overeengekomen” (deed in Dutch)
Other provision: “Bevoegdheden bestuursorgaan, behalve wet of statuten aan algemene vergadering voorbehouden” (deed in Dutch)
Other provision: “Vergoeding bestuurders, algemene kosten,los van representatie-,reis-en verplaatsingskosten” (deed in Dutch)
Other provision: “Alleen of gezamenlijk zoals bestuursorgaan bepaalt, dagelijks bestuur” (deed in Dutch)
Other provision: “Elektronische algemene vergadering, bestuur kan deelname op afstand bieden via door vennootschap ter beschikking gesteld elektronisch…” (deed in Dutch)
Other provision: “Zittingen-processen-verbaal, neergelegd in register bewaard op zetel, ondertekend door bureauleden en aanwezige aandeelhouders die erom…” (deed in Dutch)
Other provision: “Verdaging, geen afbreuk aan andere besluiten tenzij vergadering anders beslist” (deed in Dutch)
Other provision: “Bestemming winst-reserves, algemene vergadering op voorstel bestuursorgaan” (deed in Dutch)
Other provision: “Winst lopend boekjaar of winst voorgaand boekjaar zolang jaarrekening niet goedgekeurd, verminderd met overgedragen verlies of vermeerderd…” (deed in Dutch)
Other provision: “Uitvoering statuten, woonstkeuze” (deed in Dutch)
Other provision: “Gerechtelijke bevoegdheid, vennootschap, aandeelhouders, bestuurders, commissarissen, vereffenaars” (deed in Dutch)
Other provision: “Bepalingen WVV waarvan niet geldig afgeweken geacht ingeschreven, gemeen recht” (deed in Dutch)
5 more provisions in the deed, see the deed of 01-02-2024

deed of 01-02-2024